Attal M - Search Results

1

Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in refractory lymphoma patients undergoing autologous bone marrow transplantation.

Schlaifer D, Attal M, Huguet F, Canal P, Laurent G, Pris J. Schlaifer D, et al. Among authors: attal m. Semin Hematol. 1994 Apr;31(2 Suppl 3):31. Semin Hematol. 1994. PMID: 8073306 No abstract available.

2

Maintenance treatment with recombinant alpha interferon after autologous bone marrow transplantation for aggressive myeloma in first remission after conventional induction chemotherapy.

Attal M, Huguet F, Schlaifer D, Payen C, Lassoued S, Laroche M, Rossi JF, Fournie B, Mazieres B, Pris J, et al. Attal M, et al. Bone Marrow Transplant. 1991 Aug;8(2):125-8. Bone Marrow Transplant. 1991. PMID: 1933053

3

Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in patients with refractory lymphoma undergoing autologous bone marrow transplantation.

Attal M, Canal P, Schlaifer D, Chatelut E, Dezeuze A, Huguet F, Payen C, Pris J, Laurent G. Attal M, et al. J Clin Oncol. 1994 Jan;12(1):141-8. doi: 10.1200/JCO.1994.12.1.141. J Clin Oncol. 1994. PMID: 8270970 Clinical Trial.

4

Intensive combined therapy for previously untreated aggressive myeloma.

Attal M, Huguet F, Schlaifer D, Payen C, Laroche M, Fournie B, Mazieres B, Pris J, Laurent G. Attal M, et al. Blood. 1992 Mar 1;79(5):1130-6. Blood. 1992. PMID: 1536941 Free article. Clinical Trial.

5

[Magnetic resonance imaging in the bone sites of malignant non-Hodgkin's lymphoma. Apropos of 16 cases].

Assoun J, Poey C, Attal M, Huguet F, De Haldat F, Giron J, Maquin P, Pris J, Railhac JJ. Assoun J, et al. Among authors: attal m. Ann Radiol (Paris). 1991;34(6-7):383-6, 389-92. Ann Radiol (Paris). 1991. PMID: 1822661 French.

6

Immunohistochemical detection of multidrug resistance associated P-glycoprotein in stromal cells of malignant lymphomas.

Schlaifer D, Brousset P, Attal M, Voigt JJ, Laurent G, Delsol G. Schlaifer D, et al. Among authors: attal m. Nouv Rev Fr Hematol (1978). 1990;32(5):365-7. Nouv Rev Fr Hematol (1978). 1990. PMID: 1983081

7

Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial.

Attal M, Schlaifer D, Rubie H, Huguet F, Charlet JP, Bloom E, Lemozy J, Massip P, Pris J, Laurent G. Attal M, et al. J Clin Oncol. 1991 May;9(5):865-70. doi: 10.1200/JCO.1991.9.5.865. J Clin Oncol. 1991. PMID: 2016630 Clinical Trial.

8

[Initial antibacterial prophylaxis after bone marrow allograft. Pilot study with systemic vancomycin].

Rubie H, Attal M, Lemozy J, Massip P, Huguet F, Pris J, Robert A, Régnier C. Rubie H, et al. Among authors: attal m. Pathol Biol (Paris). 1988 Sep;36(7):912-4. Pathol Biol (Paris). 1988. PMID: 3059276 French.

9

Epstein-Barr virus in familial Hodgkin's disease.

Schlaifer D, Rigal-Huguet F, Robert A, Attal M, Abbal M, Fonck Y, Laurent G, Pris J, Delsol G, Brousset P. Schlaifer D, et al. Among authors: attal m. Br J Haematol. 1994 Nov;88(3):636-8. doi: 10.1111/j.1365-2141.1994.tb05089.x. Br J Haematol. 1994. PMID: 7819081

10

bcl-2 proto-oncogene and Epstein-Barr virus latent membrane protein-1 expression in AIDS-related lymphoma.

Schlaifer D, Brousset P, Attal M, Massip P, Payen C, Marchou B, Huguet F, Muller C, Laurent G, Pris J, et al. Schlaifer D, et al. Among authors: attal m. Histopathology. 1994 Jul;25(1):77-82. doi: 10.1111/j.1365-2559.1994.tb00601.x. Histopathology. 1994. PMID: 7959648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters